22 September 2020 17:43 UTC
~ As social distancing measures have declined, demand for medical tests other than COVID-19 increases ~
GREENVILLE, South Carolina – (COMMERCIAL THREAD– At the start of the pandemic, the nation began practicing social distancing, and subsequently, many stopped scheduling visits with their doctors. Labs like Premier Medical Laboratory Services suddenly focused much of their effort on delivering a high volume of testing for COVID-19. Now, as more businesses and schools have reopened, less of the population has continued to practice extreme social distancing. As a result, more patients are returning to their doctors’ offices for routine checkups and other health needs other than the coronavirus.
With this, PMLS, recently named one of the Best genetic diagnostics companies of 2020, says they are starting to see an increase in demand for the tests they offer to meet various medical diagnostic needs outside of COVID-19. Some of these tests included are their pharmacogenomics, advanced cardiovascular testing, and women’s health and wellness and diabetes panels.
“We continue to process up to 50,000 COVID-19 tests per day, but we are pleased to see an increase in orders for the other tests we offer,” said Kevin Murdock, founder of Premier Medical Laboratory Services. “We know that our tests provide vital information for physicians so they can best plan the appropriate care for their patients. “
Including their COVID-19 test portfolio, all PMLS tests processed in their 40,000 square foot laboratory are performed with the latest scientific and technological advancements to provide the most advanced and comprehensive test results. For example, PMLS’s MDDiabeticPro panel includes the revolutionary DIABETESpredict test, which is the first predictive genetic test of its kind for type 2 diabetes developed in collaboration with world-renowned doctors and scientists from Harvard and MIT. The DIABETESpredict test is expected to mark a new era in the prevention and care of diabetes by assessing the risk of developing the disease by examining individual genetic profiles and is currently only available in the United States through the PMLS.
PMLS’s cardiovascular panel, MDHeartPro, offers a more comprehensive overview of a patient’s cardiovascular health than the standard lipid profile that is commonly ordered. In addition to the standard lipid panel, MDHeartPro includes tests that identify plaque buildup, lipid particle size, hereditary factors, and other advanced risk factors.
At PMLS entirely COLA and CLIA regulated laboratory, many of their processes are automated with advanced laboratory equipment. Using a cloud-based lab information management system, OnGen, PMLS communicates real-time results to physicians directly from their lab equipment. For this reason, PMLS is able to process hundreds of thousands of COVID-19 tests per month while increasing testing capacity for its other molecular diagnostic offerings without compromising the accuracy or timeliness of results.
For more information on Premier Medical Laboratory Services, please visit www.PreMedInc.com or dial 1.877.335.2455.
ABOUT PREMIER MEDICAL LABORATORY
Premier Medical Laboratory Services (PMLS) is a CLIA and COLA regulated laboratory based in Greenville, South Carolina, focused on providing clinically meaningful results to physicians. Premier Medical Laboratory Services offers a variety of highly specialized tests including: the only molecular predisposition test for type II diabetes available in the United States, advanced cardiovascular testing, hereditary cancer screening, carrier screening, panels women’s health, pharmacogenomics, serum allergy testing, blood well-being, Hepatitis C genotyping, respiratory pathogens, gastrointestinal pathogens, etc. In addition to its specialty programs, Premier Medical Laboratory offers a comprehensive menu of general chemistry, immunoassay, and hematology tests. The company is also proud to offer a patient friendly billing policy.
For more information, please visit www.PreMedInc.com or dial 1.877.335.2455.